330 related articles for article (PubMed ID: 17980561)
21. Synthesis and in vitro evaluation of a novel thiolated chitosan.
Kafedjiiski K; Krauland AH; Hoffer MH; Bernkop-Schnürch A
Biomaterials; 2005 Mar; 26(7):819-26. PubMed ID: 15350788
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro evaluation of a novel chitosan-glutathione conjugate.
Kafedjiiski K; Föger F; Werle M; Bernkop-Schnürch A
Pharm Res; 2005 Sep; 22(9):1480-8. PubMed ID: 16132360
[TBL] [Abstract][Full Text] [Related]
23. Development and in vivo bioavailability study of an oral fondaparinux delivery system.
Vetter A; Perera G; Leithner K; Klima G; Bernkop-Schnürch A
Eur J Pharm Sci; 2010 Nov; 41(3-4):489-97. PubMed ID: 20705133
[TBL] [Abstract][Full Text] [Related]
24. Chitosan-graft-6-mercaptonicotinic acid: synthesis, characterization, and biocompatibility.
Millotti G; Samberger C; Fröhlich E; Bernkop-Schnürch A
Biomacromolecules; 2009 Nov; 10(11):3023-7. PubMed ID: 19821557
[TBL] [Abstract][Full Text] [Related]
25. Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil.
Kast CE; Guggi D; Langoth N; Bernkop-Schnürch A
Pharm Res; 2003 Jun; 20(6):931-6. PubMed ID: 12817900
[TBL] [Abstract][Full Text] [Related]
26. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
Krauland AH; Guggi D; Bernkop-Schnürch A
Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914
[TBL] [Abstract][Full Text] [Related]
27. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery.
Kafedjiiski K; Jetti RK; Föger F; Hoyer H; Werle M; Hoffer M; Bernkop-Schnürch A
Int J Pharm; 2007 Oct; 343(1-2):48-58. PubMed ID: 17544606
[TBL] [Abstract][Full Text] [Related]
29. Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties.
Sakloetsakun D; Iqbal J; Millotti G; Vetter A; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2011 Jun; 37(6):648-55. PubMed ID: 21561400
[TBL] [Abstract][Full Text] [Related]
30. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of a novel cationic thiolated polymer.
Rahmat D; Sakloetsakun D; Shahnaz G; Perera G; Kaindl R; Bernkop-Schnürch A
Int J Pharm; 2011 Jun; 411(1-2):10-7. PubMed ID: 21382457
[TBL] [Abstract][Full Text] [Related]
32. Thiomers for oral delivery of hydrophilic macromolecular drugs.
Bernkop-Schnürch A; Hoffer MH; Kafedjiiski K
Expert Opin Drug Deliv; 2004 Nov; 1(1):87-98. PubMed ID: 16296722
[TBL] [Abstract][Full Text] [Related]
33. In vivo evaluation of thiolated chitosan tablets for oral insulin delivery.
Millotti G; Laffleur F; Perera G; Vigl C; Pickl K; Sinner F; Bernkop-Schnürch A
J Pharm Sci; 2014 Oct; 103(10):3165-70. PubMed ID: 25139279
[TBL] [Abstract][Full Text] [Related]
34. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation.
Roldo M; Hornof M; Caliceti P; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2004 Jan; 57(1):115-21. PubMed ID: 14729087
[TBL] [Abstract][Full Text] [Related]
35. Improved paracellular uptake by the combination of different types of permeation enhancers.
Guggi D; Bernkop-Schnürch A
Int J Pharm; 2005 Jan; 288(1):141-50. PubMed ID: 15607266
[TBL] [Abstract][Full Text] [Related]
36. Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats.
Merzlikine A; Rotter C; Rago B; Poe J; Christoffersen C; Thomas VH; Troutman M; El-Kattan A
Drug Dev Ind Pharm; 2009 Sep; 35(9):1082-91. PubMed ID: 19294548
[TBL] [Abstract][Full Text] [Related]
37. Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats.
Anwar M; Warsi MH; Mallick N; Akhter S; Gahoi S; Jain GK; Talegaonkar S; Ahmad FJ; Khar RK
Eur J Pharm Sci; 2011 Oct; 44(3):241-9. PubMed ID: 21864678
[TBL] [Abstract][Full Text] [Related]
38. The use of thiolated polymers as carrier matrix in oral peptide delivery--proof of concept.
Bernkop-Schnürch A; Pinter Y; Guggi D; Kahlbacher H; Schöffmann G; Schuh M; Schmerold I; Del Curto MD; D'Antonio M; Esposito P; Huck C
J Control Release; 2005 Aug; 106(1-2):26-33. PubMed ID: 15939501
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
40. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
Fan B; Xing Y; Zheng Y; Sun C; Liang G
Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]